Vaginal Inserts Market

Vaginal Inserts Market Overview

Global Vaginal Inserts demand is projected to be valued at US$ 1.65 Billion in 2022, forecast to grow at a CAGR of 5.2% to be valued at US$ 2.7 Billion from 2022 to 2032. Growth is attributed to the rising demand for renovation projects and development in residential and commercial construction.

Vaginal Inserts are solid dosage drug form that is inserted into the vagina with the help of a special applicator. Vaginal inserts have advantages over other dosage forms as it will increase the local concentration of the drug and are also beneficial in refractory cases. Drugs taken in the form of vaginal inserts melt inside the body and absorb directly into the bloodstream.

Vaginal inserts can be used for several indications. Such as birth control, fungal infections, vaginal dryness, hormone supplementation, and vitamin supplementation.

Which are Some Prominent Drivers Spearheading Vaginal Inserts Market Growth?

The global vaginal Inserts market has witnessed growth due to the increasing use of vaginal inserts in birth control, fungal infections, vaginal dryness, hormone supplementation, and vitamin supplementation. With growing awareness about birth control, the use of contraceptive vaginal contraceptives is gaining popularity over conventional contraceptive pills due to its fewer side effects and also a major reason for the growth of the vaginal inserts market.

In the U.S. vaginal candidiasis is the second most common type vaginal infection next to bacterial vaginal infections. Clotrimazole vaginal inserts, Monistat 3 vaginal inserts, and Terconazole vaginal inserts are the first line of treatment for vaginal candidiasis. The incidence of vaginal candidiasis is rising globally. The rising incidence of vaginal candidiasis which required to use vaginal inserts for treatment is a vital factor that positively influences the growth of the market.

Moreover, the rising use of vaginal inserts for estrogen supplements, menstrual pain relief, and the treatment of vaginal dryness also fuelling the vaginal inserts market.

What are the Challenges Faced by the Vaginal Inserts Industry?

Although few factors such as mucosal irritation, patient compliance, and erratic and undesired absorption can restrain the concerned market.

Why is Asia-Pacific Emerging as an Opportunistic Vaginal Inserts Market?

Asia-Pacific accounted for the highest market share in 2020. The rise in the number of women populations in countries like India and China along with the rising inclination of females towards maintaining personal hygiene has driven the sales of feminine hygiene products ultimately contributing to the growth of the overall market. This awareness about vaginal hygiene has created a plethora of growth opportunities for vaginal inserts in the region.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to the Growth of the Vaginal Inserts Market?

Owing to the increased disposal of income and enhanced efforts by the government agencies towards increasing the awareness of intimate hygiene & the upward trend toward female hygiene products, the demand for vaginal inserts has increased in the European region.

As per the WHO’s report, the European Medicines Agency (EMA) has given approval to the dapivirine ring for HIV prevention for women in high HIV burden settings. An EMA positive opinion paves the way for regulatory approvals for the ring in countries where women could benefit from additional HIV prevention options. 

Why does North America Hold a Significant Share in the Vaginal Inserts Market?

North America’s Vaginal Inserts market is expanding because of the high adoption rate and it will remain dominant over the period of forecast due to the rising incidence of vaginal candidiasis and raising awareness for feminine hygiene.

As per market research, Feminine Hygiene products sales have increased tremendously in recent years, despite continued price pressure and fierce competition. Development in the organized retail market, technical advancements, and swelling demand for organic products has been the other factors driving the growth of the feminine hygiene products market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Market Competition

Some of the key participants present in the global demand for Vaginal Inserts market include Meyer Organics Pvt Ltd, Rapross Pharmaceuticals Pvt Ltd, Endocare India, Skymax Laboratories Pvt Ltd, Indica Laboratories Pvt Ltd, Sanzyme Ltd, Hetero Drugs Ltd, Glenmark Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Aristo Pharmaceuticals Pvt Ltd.

• Meyer Organics Pvt Ltd has recently developed Candifem vaginal tablet containing ornidazole and miconazole. It is effective against vaginal infections caused by Candida species, Torulopsis species, Trichomonas vaginalis, and certain gram-positive and gram-negative microorganisms.

Report Scope

Key Segments Profiled in the Vaginal Inserts Industry Survey

By Product Type:

• Vaginal Tablets
• Vaginal Capsules
• Vaginal Suppositories

By Applications:

• Vaginal Inserts for Birth Control
• Vaginal Inserts for Feminine Hygiene
• Vaginal Inserts for Fungal Infections
• Vaginal Inserts for Other Applications

By Distribution Channel:

• Vaginal Inserts Sales through Retail Pharmacy
• Vaginal Inserts Sales through Hospital Pharmacy
• Vaginal Inserts Sales through Online Pharmacy
• Vaginal Inserts Sales through Fertilization Centers

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa